INSTAGE (TM) : A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib coadministrated with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Nintedanib (Primary) ; Sildenafil
- Indications Idiopathic pulmonary fibrosis; Lung disorders
- Focus Therapeutic Use
- Acronyms INSTAGE; INSTAGE (TM)
- Sponsors Boehringer Ingelheim
- 23 May 2018 Study design presented at the 114th International Conference of the American Thoracic Society
- 24 Apr 2018 Status changed from active, no longer recruiting to completed.
- 20 Nov 2017 Status changed from recruiting to active, no longer recruiting.